Koninklijke Philips EBITDA Margin 2012-2026 | PHG
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Koninklijke Philips (PHG) over the last 10 years. The current EBITDA margin for Koninklijke Philips as of June 30, 2026 is .
| Koninklijke Philips EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2026-06-30 | $20.58B | $3.39B | 16.48% |
| 2026-03-31 | $20.43B | $3.02B | 14.79% |
| 2025-12-31 | $20.18B | $2.88B | 14.29% |
| 2025-09-30 | $19.08B | $1.99B | 10.44% |
| 2025-06-30 | $18.86B | $2.11B | 11.21% |
| 2025-03-31 | $18.81B | $1.58B | 8.37% |
| 2024-09-30 | $18.97B | $0.50B | 2.61% |
| 2024-06-30 | $18.60B | $0.51B | 2.73% |
| 2023-06-30 | $18.89B | $-0.27B | -1.43% |
| 2023-03-31 | $18.85B | $-0.26B | -1.38% |
| 2022-06-30 | $19.63B | $0.76B | 3.86% |
| 2021-06-30 | $20.30B | $1.10B | 5.42% |
| 2020-06-30 | $19.93B | $1.28B | 6.41% |
| 2019-06-30 | $22.93B | $2.31B | 10.08% |
| 2018-06-30 | $24.26B | $2.79B | 11.49% |
| 2017-06-30 | $25.77B | $3.21B | 12.45% |
| 2016-12-31 | $27.13B | $3.52B | 12.96% |
| 2016-09-30 | $27.08B | $2.85B | 10.52% |
| 2016-06-30 | $26.99B | $2.71B | 10.05% |
| 2016-03-31 | $26.98B | $2.69B | 9.96% |
| 2015-12-31 | $26.92B | $2.58B | 9.57% |
| 2015-09-30 | $26.06B | $2.33B | 8.93% |
| 2015-06-30 | $26.93B | $1.87B | 6.94% |
| 2015-03-31 | $27.58B | $1.99B | 7.21% |
| 2014-12-31 | $28.44B | $2.25B | 7.92% |
| 2014-09-30 | $30.72B | $3.43B | 11.16% |
| 2014-06-30 | $30.80B | $4.22B | 13.70% |
| 2014-03-31 | $30.92B | $4.42B | 14.29% |
| 2013-12-31 | $30.99B | $4.49B | 14.48% |
| 2013-09-30 | $31.41B | $3.60B | 11.45% |
| 2013-06-30 | $31.96B | $3.69B | 11.56% |
| 2013-03-31 | $31.77B | $3.26B | 10.27% |
| 2012-12-31 | $32.19B | $3.49B | 10.85% |
| 2012-09-30 | $31.35B | $3.44B | 10.98% |
| 2012-06-30 | $30.80B | $2.90B | 9.41% |
| 2012-03-31 | $31.11B | $3.13B | 10.04% |
| 2011-12-31 | $31.33B | $3.36B | 10.71% |
| 2011-09-30 | $32.59B | $4.29B | 13.15% |
| 2011-06-30 | $33.09B | $4.76B | 14.39% |
| 2011-03-31 | $33.49B | $4.82B | 14.40% |
| 2010-12-31 | $33.77B | $4.55B | 13.47% |
| 2010-09-30 | $34.44B | $5.85B | 16.97% |
| 2010-06-30 | $34.60B | $5.79B | 16.74% |
| 2010-03-31 | $34.14B | $4.21B | 12.33% |
| 2009-12-31 | $32.91B | $3.40B | 10.32% |
| 2009-09-30 | $32.42B | $1.09B | 3.37% |
| 2009-06-30 | $33.85B | $0.37B | 1.09% |
| 2009-03-31 | $36.52B | $1.80B | 4.93% |
| 2008-12-31 | $38.81B | $2.27B | 5.86% |
| 2008-09-30 | $40.05B | $3.52B | 8.78% |
| 2008-06-30 | $39.47B | $3.41B | 8.63% |
| 2008-03-31 | $37.59B | $3.34B | 8.88% |
| 2007-12-31 | $36.50B | $3.28B | 8.97% |
| 2007-09-30 | $35.52B | $5.34B | 15.03% |
| 2007-06-30 | $34.61B | $5.05B | 14.60% |
| 2007-03-31 | $35.94B | $5.19B | 14.44% |
| 2006-12-31 | $36.96B | $5.32B | 14.38% |
| 2006-09-30 | $37.80B | $3.13B | 8.27% |
| 2006-06-30 | $39.05B | $4.10B | 10.50% |
| 2006-03-31 | $39.12B | $4.53B | 11.57% |
| 2005-12-31 | $38.95B | $4.65B | 11.93% |
| 2005-09-30 | $44.75B | $8.02B | 17.91% |
| 2005-06-30 | $44.29B | $8.02B | 18.10% |
| 2005-03-31 | $43.45B | $7.60B | 17.49% |
| 2004-12-31 | $43.03B | $7.50B | 17.44% |
| 2004-09-30 | $36.64B | $0.81B | 2.20% |
| 2004-06-30 | $35.68B | $1.05B | 2.95% |
| 2004-03-31 | $34.33B | $0.19B | 0.56% |
| 2003-12-31 | $33.02B | $-0.02B | -0.06% |
| 2003-09-30 | $31.21B | $0.06B | 0.18% |
| 2003-06-30 | $30.53B | $-0.54B | -1.75% |
| 2003-03-31 | $30.46B | $-0.41B | -1.34% |
| 2002-12-31 | $30.11B | $-0.49B | -1.63% |
| 2002-09-30 | $29.48B | $-18.60B | -63.10% |
| 2002-06-30 | $28.64B | $-12.36B | -43.17% |
| 2002-03-31 | $27.92B | $-5.28B | -18.91% |
| 2001-12-31 | $28.84B | $2.30B | 7.96% |
| 2001-09-30 | $30.28B | $-0.20B | -0.65% |
| 2001-06-30 | $32.42B | $2.02B | 6.23% |
| 2001-03-31 | $34.35B | $3.84B | 11.17% |
| 2000-12-31 | $35.03B | $4.54B | 12.97% |
| 2000-09-30 | $35.19B | $6.82B | 19.38% |
| 2000-06-30 | $34.86B | $6.47B | 18.55% |
| 2000-03-31 | $33.97B | $5.57B | 16.40% |
| 1999-12-31 | $33.40B | $4.92B | 14.72% |
| 1999-09-30 | $31.72B | $33.08B | 104.30% |
| 1999-06-30 | $31.79B | $32.66B | 102.75% |
| 1999-03-31 | $32.99B | $33.40B | 101.24% |
| 1998-12-31 | $33.89B | $33.89B | 100.00% |
| 1998-09-30 | $37.85B | $37.85B | 100.00% |
| 1998-06-30 | $38.92B | $38.92B | 100.00% |
| 1998-03-31 | $39.01B | $39.01B | 100.00% |
| 1997-12-31 | $39.13B | $39.13B | 100.00% |
| 1997-09-30 | $39.39B | $39.39B | 100.00% |
| 1997-06-30 | $39.63B | $39.63B | 100.00% |
| 1997-03-31 | $40.14B | $40.14B | 100.00% |
| 1996-12-31 | $40.97B | $40.97B | 100.00% |
| 1996-06-30 | $28.53B | $28.53B | 100.00% |
| 1996-03-31 | $28.47B | $28.47B | 100.00% |
| 1995-09-30 | $38.67B | $38.67B | 100.00% |
| 1995-06-30 | $37.11B | $37.11B | 100.00% |
| 1995-03-31 | $35.48B | $35.48B | 100.00% |
| 1994-12-31 | $33.79B | $33.79B | 100.00% |
| 1994-06-30 | $22.52B | $22.52B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $24.651B | $20.173B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.385B | 19.60 |
| Medtronic (MDT) | Ireland | $119.983B | 16.40 |
| Stryker (SYK) | United States | $108.118B | 20.21 |
| EssilorLuxottica (ESLOY) | France | $79.433B | 0.00 |
| Boston Scientific (BSX) | United States | $65.288B | 14.03 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.930B | 0.00 |
| Medline (MDLN) | United States | $42.846B | 0.00 |
| Agilent Technologies (A) | United States | $41.387B | 24.22 |
| ResMed (RMD) | United States | $32.167B | 19.96 |
| GE HealthCare Technologies (GEHC) | United States | $29.021B | 13.88 |
| Terumo (TRUMY) | Japan | $21.625B | 20.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.414B | 11.38 |
| Baxter (BAX) | United States | $12.336B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.926B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.854B | 39.71 |
| Demant (WILYY) | Denmark | $9.592B | 0.00 |
| Insulet (PODD) | United States | $9.557B | 23.48 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.548B | 20.15 |
| Raia Drogasil SA - (RADLY) | $4.931B | 0.00 | |
| Haemonetics (HAE) | United States | $4.837B | 21.22 |
| BillionToOne (BLLN) | United States | $4.757B | 144.03 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.142B | 17.54 |
| ICU Medical (ICUI) | United States | $3.939B | 23.52 |
| AtriCure (ATRC) | United States | $2.838B | 242.57 |
| Neogen (NEOG) | United States | $2.606B | 45.96 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.356B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.256B | 10.77 |
| Trulieve Cannabis (TRLV) | United States | $2.238B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.207B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.894B | 5.46 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.736B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.733B | 221.44 |
| Phibro Animal Health (PAHC) | United States | $1.459B | 11.20 |
| Green Thumb Industries (GTBIF) | United States | $1.428B | 15.23 |
| Kestra Medical Technologies (KMTS) | United States | $1.410B | 0.00 |
| Omeros (OMER) | United States | $1.264B | 6.40 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.094B | 0.00 |
| CeriBell (CBLL) | United States | $0.934B | 0.00 |
| InMode (INMD) | Israel | $0.856B | 11.91 |
| AdaptHealth (AHCO) | United States | $0.802B | 16.80 |
| VAREX IMAGING (VREX) | United States | $0.777B | 17.09 |
| QuidelOrtho (QDEL) | United States | $0.763B | 8.24 |
| Glass House Brands (GLAS) | United States | $0.760B | 0.00 |
| Valneva SE (VALN) | France | $0.633B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.582B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.564B | 0.00 |
| Brainsway (BWAY) | Israel | $0.548B | 30.98 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Cerus (CERS) | United States | $0.514B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.512B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.438B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.373B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.337B | 24.56 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.268B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 13.14 |
| High Tide (HITI) | Canada | $0.234B | 52.60 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 21.55 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.152B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Quanterix (QTRX) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.088B | 121.38 |
| Accendra Health (ACH) | United States | $0.086B | 4.87 |
| FitLife Brands (FTLF) | United States | $0.086B | 11.30 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.052B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.12 |
| Nephros (NEPH) | United States | $0.048B | 40.27 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.037B | 17.71 |
| United-Guardian (UG) | United States | $0.033B | 13.26 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.021B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |